Cryoport, Inc. (CYRX)
NASDAQ: CYRX · Real-Time Price · USD
17.43
+0.07 (0.40%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Cryoport Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 186.45 | 176.18 | 156.77 | 168.66 | 237.28 | 222.61 |
Revenue Growth | 12.14% | 12.38% | -7.05% | -28.92% | 6.59% | 182.87% |
Gross Profit Gross Profit Growth | 87.77 | 83.05 | 69.66 | 75.33 | 103.87 | 96.58 |
Operating Income Operating Income Growth | -29.22 | -31.63 | -56.04 | -51.57 | -31.9 | -17.83 |
Net Income Net Income Growth | -45.39 | 70.3 | -122.76 | -107.59 | -45.33 | -283.72 |
Earnings Per Share EPS Growth | -0.91 | 1.40 | -2.49 | -2.21 | -0.93 | -6.18 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
BioLogistics Solutions BioLogistics Solutions Growth | 83.76 | 78.14 | 67.02 | 65.91 | 124.8 | - |
BioStorage/BioServices BioStorage/BioServices Growth | 20.37 | 18.36 | 15.03 | 13.59 | 9.08 | - |
Life Sciences Products Life Sciences Products Growth | 82.32 | 79.68 | 74.73 | 89.17 | 103.4 | 103.54 |
Revenue (Total) Revenue (Total) Growth | 186.45 | 176.18 | 156.77 | 168.66 | 237.28 | 222.61 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 396.69 | 411.21 | 250.6 | 456.76 | 523.32 | 628.8 |
Total Debt Total Debt Growth | 232.02 | 230.72 | 242.54 | 416 | 435.91 | 427.06 |
Net Cash (Debt) Net Cash Growth | 164.68 | 180.49 | 8.06 | 40.75 | 87.42 | 201.74 |
Net Cash Growth | -16.60% | 2139.89% | -80.23% | -53.38% | -56.67% | - |
Net Cash Per Share Net Cash Per Share Growth | 3.29 | 3.60 | 0.16 | 0.84 | 1.78 | 4.39 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 7.97 | -8.58 | -16.32 | -0.76 | -1.85 | 8.13 |
Capital Expenditures CapEx Growth | -28 | -16.44 | -17.25 | -38.79 | -22.11 | -23.88 |
Free Cash Flow Free Cash Flow Growth | -20.03 | -25.02 | -33.58 | -39.54 | -23.96 | -15.76 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 47.08% | 47.14% | 44.43% | 44.66% | 43.78% | 43.38% |
Operating Margin | -15.67% | -17.95% | -35.74% | -30.58% | -13.45% | -8.01% |
Pretax Margin | -16.63% | -18.26% | -66.56% | -49.93% | -14.79% | -123.02% |
Profit Margin | -24.34% | 39.90% | -78.30% | -63.79% | -19.11% | -127.46% |
FCF Margin | -10.74% | -14.20% | -21.42% | -23.45% | -10.10% | -7.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 6.84 | - | - | - | - |
Forward PE | - | 113.16 | 113.16 | 113.16 | 113.16 | 208.54 |
PS Ratio | 4.73 | 2.73 | 2.45 | 4.50 | 3.58 | 13.12 |